Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Has the Same Effect as Gonadotropin-Releasing Hormone Agonist Injections in Terms of Preparation for Transcervical Resection Myomectomy

For preparing the optimal condition in transcervical resection (TCR) surgery, gonadotropin-releasing hormone (GnRH) agonist has been utilized. Recently, an oral GnRH antagonist (relugolix) is available and acts directly on GnRH receptor, avoiding flare up and reducing blood E2 levels rapidly. We ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Ito, Mika, Yoshino, Osamu, Hiraoka, Takehiro, Ono, Yosuke, Tanaka, Kouta, Iwahata, Shunsuke, Honda, Masako, Furue, Akiko, Nishijima, Junichi, Shimoda, Takahito, Iwase, Haruko, Miki, Akinori, Tagaya, Hikaru, Hirata, Shuji, Unno, Nobuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844050/
https://www.ncbi.nlm.nih.gov/pubmed/36660323
http://dx.doi.org/10.4103/gmit.gmit_9_22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844050/
https://www.ncbi.nlm.nih.gov/pubmed/36660323
http://dx.doi.org/10.4103/gmit.gmit_9_22

Ejemplares similares